Work

Transcatheter aortic valve replacement embolization: A fleeing, formidable, yet defeatable foe

Year: 2024

Type: article

Abstract: Transcatheter aortic valve replacement (TAVR) is an innovative treatment for aortic valve pathology. TAVRs are performed by either balloon-expandable (BEV) or self-expandable bioprosthetic valve (SEV) deployment across the aortic valve annulus. Fixation of the valve in place relies upon the radial force applied by the stent framing on the surrounding tissue and anchoring of the valve on rigid structures of the aortic annulus. When the valve loses contact with the annulus and moves from its intended location, embolization occurs.

Source: JTCVS structural and endovascular.

DOI: 10.1016/j.xjse.2024.100030

Authors: Maxwell C. Braasch, Ali M. Alakhtar, Alan Zajarias, Tsuyoshi Kaneko

Institutions: Washington University in St. Louis, Qassim University

Language: English

Topic: Cardiac Valve Diseases and Treatments

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,500